My husband diagnosed MM July '22 at age 53. He did Induction RVD followed by ASCT. For maintenance therapy he was offered a clinical trial Revlimid and Daratumumab. On Dar injection day we were shocked that they were adding Dex. and Singulair (Black Box label warning on this). Neither drug is not listed in the clinical trial information and we were told this study didn't include Dex. The Trial name is DRAMMATIC. Is anyone in this study and if so, is Dex being required? We are considering exiting the trial. Also, considering getting a second opinion on his MM treatment.